Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanostec is a private U.S. consumer healthcare and medical device company focused on non-drug nasal airflow aids for breathing and sleep-related symptoms. The company markets FDA-registered nasal dilator products including Max-Air Nose Cones, Sinus Cones, and SwirlZZ, which are designed to stent open nasal airways and relieve snoring, nasal obstruction, sinus congestion, and deviated septum-related breathing difficulties. Its business appears centered on direct-to-consumer sales and retail pharmacy distribution rather than prescription therapeutics or a traditional drug-development pipeline. Sanostec operates in the respiratory and sleep-support segment of healthcare with commercial products rather than clinical-stage biotech assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanostec.